Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Molecular Urology|November 4, 2000
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapyM C Gong, S S Chang, F Watt, et al.
Molecular Urology|November 4, 2000
Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancerW R Fair, J E Betancourt
Molecular Urology|November 4, 2000
Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experienceF M Debruyne, W P Witjes
Molecular Urology|November 4, 2000
Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study groupM B Garnick, M Campion
Molecular Urology|November 4, 2000
Urinary incontinence after treatment for localized prostate cancerR J Krane
Molecular Urology|January 13, 2001
Oxalate synthesis in humans: assumptions, problems, and unresolved issuesR P Holmes
Molecular Urology|January 13, 2001
Cystinuria at the turn of the millennium: clinical aspects and new molecular developmentsE Pras
Molecular Urology|January 16, 2002
Neural computation in urology: an orientationC Niederberger
Molecular Urology|November 2, 2001
Effects of Tamm-Horsfall protein and albumin on calcium oxalate crystallization and importance of sialic acidsW C Chen, H S Lin, H Y Chen, et al.
Molecular Urology|November 2, 2001
Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancerT Fukui, N Nonomura, T Tokizane, et al.
Pageof 14